Paydirt
AK
Insider

Adam Koppel

Director

Adam Koppel (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in KLRA. Across 1 priced purchase filing, the average 21-session return was -26.2% from execution and -26.2% from disclosure (delay-adjusted; derived). The largest single filing was $25.0M of KLRA (1,562,500 sh × $16.00, as filed), executed Apr 20.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
-26.2%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-26.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$25.0M
shares × price, as filed
Last traded
Apr 20
Filed Apr 20
Open performance→
Volume by month
$25.0M$12.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · buys $25.0M
Buys $25.0M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
KLRA KLRA KLRA · 1 buy · 0 sells 1 filing
Recent filings
KLRAPURCHASE Kailera Therapeutics, Inc. View filing → $25.0M
1,562,500 sh × $16.00
Exec Apr 20
Filed Apr 20 · 6:08 PM ET